Cosette Pharmaceuticals appoints new VP Generics Commercial Operation

Bridgewater-based Cosette Pharmaceuticals, on Monday announced it appointed Brad Leonard as vice president, Generics Commercial Operations. In this role, Leonard will spearhead Cosette’s generics business, including Generics Sales, Marketing/Pricing, Customer Service, and Demand Planning, as the company continues its expansion in these markets.

“Cosette is in the midst of an exciting period of accelerated growth and portfolio expansion, and Brad is the right commercial leader to take our business to the next level,” Apurva Saraf, president and CEO, Cosette Pharmaceuticals, said. “Brad’s deep expertise in the pharmaceutical industry, combined with his track record of driving commercial success and fostering strategic partnerships, will be a catalyst for our continued momentum.”

Leonard played a pivotal role in the growth and success of Upsher-Smith Laboratories, LLC using a customer-focused approach to enhance their financial performance and commercial presence.

“I am honored to join Cosette at this pivotal moment in its journey,” Leonard said. “The company’s bold vision, entrepreneurial spirit, and relentless focus on innovation make this an incredibly exciting time to be part of the team. I look forward to collaborating with the talented individuals at Cosette to accelerate our commercial execution, expand our market reach, and set new standards of excellence for the customers and patients we serve.”

With 30+ years of experience in the pharmaceutical industry, Leonard is an experienced pharmaceutical executive with a robust background in pharmaceutical access and patient delivery across both generic and branded markets, cultivating and sustaining strong customer relationships, developing award-winning commercialization teams, and consistently driving sales and profit growth.